NASDAQ:NTLA | EBITDA Margin | Intellia Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-06-30-1444.84%
2026-03-31-653.44%
2025-12-31-418.52%
2025-09-30-791.45%
2025-06-30-754.62%
2025-03-31-711.55%
2024-12-31-1039.93%
2024-09-30-1560.42%
2024-06-30-1961.23%
2024-03-31-385.32%
2023-12-317168.81%
2023-03-31-871.87%
2022-12-31-796.11%
2022-03-31-1266.37%
2021-12-31-610.98%
2021-03-31-695.64%
2020-12-31-618.61%
2020-03-31-243.94%
2019-12-31-257.91%
2019-03-31-215.75%
2018-12-31-247.70%
2018-03-31-286.76%
2017-12-31-358.16%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-637.23%
2024-12-31-905.33%
2023-12-31-1395.77%
2022-12-31-864.51%
2021-12-31-789.52%
2020-12-31-224.63%
2019-12-31-233.81%
2018-12-31-283.91%
2017-12-31-254.86%
2016-12-31-188.45%